UTI - Healthcare Fund

UTI Mutual Fund

Equity › Sectoral/Thematic Regular plan IDCW SEBI riskometer: Very High
₹256.5620
-5.6352 (-2.15%)
NAV on 1 Oct 2026

NAV history

When comparing, both lines start at 100. Tradinity's reference for the category: a total-return index (dividends reinvested). The fund's declared benchmark (BSE Healthcare TRI) is not available to us as a series.

Returns

This is an IDCW (dividend) option: it pays cash out of its NAV, so returns computed from the NAV alone would understate what an investor earned. See the Growth option of the same plan for performance.

What if you had invested?

Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.

Portfolio as of 31 Aug 2026

Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. Shown from the Direct plan of this fund, which holds the same portfolio. The feed carries weights only: no quantities or rupee values.

Holdings
44
Top 5 / top 10
28.6% / 45.0%
Largest holding
8.2%
Mapped to Tradinity companies
94%
Portfolio P/E
46.8
Portfolio ROE
15.6%
Portfolio dividend yield
0.59%
Largest sector
—

Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.

Holdings

Export CSV
HoldingSectorWeight3M changeP/E
EQ - SUN PHARMACEUTICALS INDUSTRIES Healthcare 8.25% — 143.5
EQ - DIVIS LABORATORIES LTD. Healthcare 6.21% — 83.0
NET CURRENT ASSETS — 5.71% — —
EQ - AJANTA PHARMA LTD. Healthcare 4.74% — 43.2
EQ - GLAND PHARMA LTD. Healthcare 3.70% — 34.4
EQ - DR REDDYS LABORATORIES LTD. Healthcare 3.62% — 150.9
EQ - ALKEM LABORATORIES LTD Healthcare 3.29% — 29.1
EQ - APOLLO HOSPITALS ENTERPRISE LT Healthcare 3.27% — 73.1
EQ - MAX HEALTHCARE INSTITUTE LTD Healthcare 3.10% — 124.3
EQ - LUPIN LTD. Healthcare 3.09% — 13.2
EQ - CAPLIN POINT LABORATORIES LTD Healthcare 3.05% — 45.9
EQ - IPCA LABORATORIES LTD. Healthcare 2.87% — 39.8
EQ- GLOBAL HEALTH LTD. Healthcare 2.81% — 74.4
EQ - ANTHEM BIOSCIENCES LTD Healthcare 2.62% — 76.6
EQ - FORTIS HEALTHCARE LTD. Healthcare 2.36% — 255.5
EQ - RAINBOW CHILDRENS MEDICARE LTD Healthcare 2.25% — 51.3
EQ - GLENMARK PHARMACEUTICALS LTD. Healthcare 2.23% — 316.1
EQ - MARKSANS PHARMA LTD. Healthcare 2.23% — 46.8
EQ - COHANCE LIFESCIENCES LIMITED Healthcare 2.21% — 96.3
EQ- JUPITER LIFE LINE HOSPITALS LTD Healthcare 2.17% — 9.0
EQ - AUROBINDO PHARMA LTD. Healthcare 2.10% — 37.5
EQ - PROCTOR & GAMBLE HEALTH LTD Healthcare 2.00% — 24.7
EQ - ASTER DM QUALITY CARE LIMITED Healthcare 1.89% — 205.8
EQ - SAI LIFE SCIENCES LTD Healthcare 1.79% — 89.9
EQ - DR LAL PATHLABS LTD. Healthcare 1.61% — 38.4
EQ - METROPOLIS HEALTHCARE LTD Healthcare 1.56% — 28.1
EQ - VIYASH SCIENTIFIC LTD Healthcare 1.54% — 161.3
EQ - CIPLA LTD. Healthcare 1.46% — 35.1
EQ - BIOCON LTD. Healthcare 1.42% — 596.5
EQ - SUDEEP PHARMA LIMITED Chemicals 1.42% — 112.8
EQ - VIJAYA DIAGNOSTIC CENTRE LTD Healthcare 1.39% — 75.9
EQ - WINDLAS BIOTEC LTD Healthcare 1.28% — 32.2
EQ - ERIS LIFESCIENCES LTD Healthcare 1.21% — 84.5
EQ - ALEMBIC PHARMACEUTICALS Healthcare 1.16% — 22.3
EQ - MANIPAL HEALTH ENTERPRISES LIMITED Healthcare 1.12% — —
EQ - PFIZER LIMITED Healthcare 1.11% — 23.9
EQ - BLUE JET HEALTHCARE LTD Healthcare 0.99% — 39.2
EQ - LAXMI DENTAL LIMITED Healthcare 0.98% — 59.2
EQ - EMCURE PHARMACEUTICALS LTD Healthcare 0.89% — 45.3
EQ - AARTI PHARMALABS LTD Healthcare 0.88% — 41.2
EQ - SANOFI CONSUMER HEALTHCARE INDIA LTD Healthcare 0.69% — 32.5
EQ - ORCHID PHARMA LTD. Healthcare 0.68% — 143.5
EQ - JUBILANT PHARMOVA LIMITED Healthcare 0.55% — 677.0
EQ - SYNGENE INTERNATIONAL LTD. Healthcare 0.45% — 62.8

This is a paid feature

Comparing more months of this fund's own portfolio history is available on paid plans.

Sign in

Fund details

Fund houseUTI Mutual Fund
AMFI scheme code100806
CategoryEquity › Sectoral/Thematic
AMFI categoryOpen Ended Schemes(Equity Scheme - Sectoral/ Thematic)
Plan / optionRegular / IDCW
ISININF789F01679
NAV history from2 Jan 2007
NAV points on record4,855

Cost and size

Expense ratio (regular, Sep 2026)
2.21%
Assets under management
₹185 crore
average, June-2026

Expense ratio by month: Oct 25 2.26% · Nov 25 2.26% · Dec 25 2.26% · Jan 26 2.27% · Feb 26 2.27% · Mar 26 2.28% · Apr 26 2.30% · May 26 2.27% · Jun 26 2.26% · Jul 26 2.22% · Aug 26 2.20% · Sep 26 2.21%

From the scheme information document

Benchmark
BSE Healthcare TRI
Not Applicable
SEBI riskometer
Very High
Registrar
KFin Technologies Limited
Minimum investment
Regular Plan-Growth- Rs.5000, Regular Plan-Reinvestment of IDCW- Rs.5000, Regular Plan-Payout of IDCW- Rs.5000, Direct Plan-Growth- Rs.5000, Direct Plan-Reinvestment of IDCW- Rs.5000, Direct Plan-Payout of IDCW- Rs.5000,
Minimum additional
Regular Plan-Growth-Rs.1000, Regular Plan-Reinvestment of IDCW-Rs.1000, Regular Plan-Payout of IDCW-Rs.1000, Direct Plan-Growth-Rs.1000, Direct Plan-Reinvestment of IDCW-Rs.1000, Direct Plan-Payout of IDCW-Rs.1000,
SIP
SIP - D-500/W-500/M-500/Q-1500; SWP - M-500/Q-500/H-500/Y-500; STP - D-100/W-1000/M-1000/Q-3000
Fund manager(s)
Mr. Kamal Gada FM 1,Not Applicable FM 2,Not Applicable FM 3

Exit load

1.00% if redeemed before 30 days from the date of allotment. Nil if redeemed on or after 30 days from the date of allotment

Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.; However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Scheme information document

Fund house: website · factsheets · monthly portfolio · annual report

Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.

Other plans of this fund

Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.